Bioseutica and BioProcess Algae sign supply agreement

In Switzerland, Bioseutica, a producer of highly purified pharmaceutical-grade Omega-3 fatty acids, and BioProcess Algae, a Rhode Island based algal feedstocks company have entered into a commercial supply agreement for the production of EPA-rich Omega-3 oils for use in concentrated EPA products for nutritional and/or pharmaceutical applications.

Under the agreement, BioProcess Algae will supply microalgal oils which will be refined by KD-Pharma’s proprietary Supercritical Fluid Technology to produce highly-concentrated vegetable sourced EPA oils. BioProcess Algae works with converting CO2 into sustainable algae feedstocks for human nutrition, animal feeds, green chemicals and biofuels.

More on the story.